David Bangsberg, MD, MPH
Browse by
Professor Dr. David Bangsberg assumes the position of Provost cum Dean of the College of Health Sciences at VinUniversity, starting from the 2023-2024 academic year.
Dr. David Bangsberg most recently served as the founding Dean of the OHSU-PSU School of Public Health in his hometown, Portland, Oregon. Under his direction, the school has made great strides in helping to expand community knowledge, understanding and interest in the importance of public health. Of note, enrollment in the school’s MPH program has increased by more than 76%. This helps to expand Oregon’s public health workforce — a crucial need as the state continues to respond to the unique impacts of the COVID-19 pandemic.
As Dean, Dr. Bangsberg implemented several programs to increase public health awareness and education. He established the School of Public Health Dean’s Scholarship Fund to help support a good and diverse student body. The fund has distributed more than $500,000 in tuition support to 54 first-generation public health students. With his influence, Dr. Bangsberg has attracted significant funding from local and federal sources for research activities at OHSU-PSU. As of 2022, the school has received over $26 million in funding to support research on health, healthcare reform, and social aspects.
Previously, Professor Bangsberg was the director of MGH Global Health at Massachusetts General Hospital, the largest teaching hospital of the Harvard Medical School. Under his leadership, MGH Global Health has transformed from a single program to an institution-wide global health initiative that now includes programs in medical technology innovation, global disaster response, cancer care, obstetrics/gynaecology, radiology, pathology, infectious diseases, and community health.
As a physician scientist, he has raised over $70 million in research and programmatic funding from federal, foundation and philanthropic sources. In 2007, he was recognized in science as the second-highest RO-1 funded HIV/AIDS researcher globally. His 498 publications on social, behavioural, virologist and immunologic aspects of HIV/AIDS have been cited over 54,000 times and earned an h-index of 116 per Google Scholar. He received the Clifford Barger mentoring award given annually to 5 of 11,000 Harvard Medical School Faculty. He has been recognised as one of the world’s top medical scientists and is among the most outstanding HIV researchers.
Copyright 2024©
Recent Submissions
-
Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women
(2023)Background: Daily, oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis (PrEP) reduces HIV acquisition for African women. Adherence is key to efficacy and patterns of adherence can be ... -
Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South Africa
(2023-12-28)Timely initiation of and adherence to antiretroviral therapy (ART) is critical for improving HIV outcomes and reducing HIV transmissibility. Social networks, or the social relationships individuals have with each other, ... -
Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South Africa
(Elsevier Ltd., 2024-01)Timely initiation of and adherence to antiretroviral therapy (ART) is critical for improving HIV outcomes and reducing HIV transmissibility. Social networks, or the social relationships individuals have with each other, ...